, South Korea
134 views
Photo from Envato

Asan Medical Centre introduces Pluvicto for prostate cancer treatment

The treatment received official marketing approval in South Korea from the Ministry of Food and Drug Safety last May.

The Theranostics Centre of South Korea’s Asan Medical Centre (AMC) Cancer Institute has introduced Pluvicto, a targetted radiopharmaceutical developed by Novartis for prostate cancer treatment.

According to AMC, the treatment utilises the radioactive isotope lutetium, which selectively binds to the prostate-specific membrane antigen (PSMA) to destroy cancer cells.

Initially, a personalised PET/CT scan is conducted using a diagnostic radiopharmaceutical that binds to PSMA. If the scan confirms PSMA overexpression, Pluvicto is administered to the patient.

The treatment, which received official marketing approval in South Korea from the Ministry of Food and Drug Safety last May, is a new alternative for prostate cancer patients who have not responded to androgen receptor pathway inhibition therapy and taxane-based chemotherapy.

 

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Saudi’s KFSHRC banks on innovation to transform healthcare
The hospital is accelerating adoption of emerging technologies to position itself as a global leader in medicine
Angkor Hospital eyes trauma centre for children
The facility will have an ICU, emergency room, operating theatre and a surgical ward.